ALK translocation and crizotinib in non-small cell lung cancer: an evolving paradigm in oncology drug development (Q39250899)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ALK translocation and crizotinib in non-small cell lung cancer: an evolving paradigm in oncology drug development |
scientific article |
Statements
1 reference
ALK translocation and crizotinib in non-small cell lung cancer: an evolving paradigm in oncology drug development (English)
1 reference
Rafael Rosell
1 reference
Giorgio Scagliotti
1 reference
Rolf A Stahel
1 reference
Nick Thatcher
1 reference
6 March 2012
1 reference
1 reference
1 reference
Identifiers
1 reference